Stock detail
Transmedics (TMDX) stock price, chart, and key data
View Transmedics stock price, chart movement, and headline metrics on Woodstock's stock detail page.

Stock detail
Transmedics
TMDX · XNAS
$80.93
-4.83%
-$4.11
Key metrics
52-week range
$3.25 - $10.00
Close price
$85.04
Market cap
$2.9B
P/E ratio
207.41
Beta
1.82
About the company
Transmedics Group Inc
TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System (OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization, and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.
Analyst rating summary
A current read on analyst sentiment from the insight feed.
Mean target
$94.22
7
Buy
/ 11
Recent calls
09/11/2026
Piper Sandler
Matthew O'Brien
Buy · Price target $100
09/11/2026
Canaccord Genuity
William Plovanic
Buy · Price target $95.00
09/11/2026
Needham
Michael Matson
Buy · Price target $106
Ticker holders
Review politician disclosures and insider transactions in tabs.
Holder directory
Select a heading to reorder by name, activity date, buy/sell, or displayed value.
#1Donald J Trump republican · Executive self |
| 1,157/2,025/2,893 |
24/5 Trading
Act on the stock when the timing works for you.
With Woodstock, you can move from chart review to order placement in one flow. Trade eligible US stocks 24/5, even outside regular market hours.
*24-hour trading is available except during system maintenance. Some stocks are not eligible for extended-hours trading.
Download the app